19-47801878-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001397346.1(TPRX1):c.1298G>A(p.Gly433Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,614,138 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001397346.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TPRX1 | NM_001397346.1 | c.1298G>A | p.Gly433Glu | missense_variant | 3/3 | ENST00000698655.1 | NP_001384275.1 | |
TPRX1 | NM_198479.3 | c.1424G>A | p.Gly475Glu | missense_variant | 4/4 | NP_940881.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TPRX1 | ENST00000698655.1 | c.1298G>A | p.Gly433Glu | missense_variant | 3/3 | NM_001397346.1 | ENSP00000513863.1 | |||
TPRX1 | ENST00000535759.2 | c.1424G>A | p.Gly475Glu | missense_variant | 4/4 | 1 | ENSP00000438832.1 | |||
TPRX1 | ENST00000322175.8 | c.950G>A | p.Gly317Glu | missense_variant | 4/4 | 1 | ENSP00000513867.1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152132Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000278 AC: 7AN: 251486Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135920
GnomAD4 exome AF: 0.0000150 AC: 22AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.0000110 AC XY: 8AN XY: 727246
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74434
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 12, 2022 | The c.1133G>A (p.G378E) alteration is located in exon 2 (coding exon 2) of the TPRX1 gene. This alteration results from a G to A substitution at nucleotide position 1133, causing the glycine (G) at amino acid position 378 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at